M. Boulanger

1.0k total citations
51 papers, 638 citations indexed

About

M. Boulanger is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Pharmacology. According to data from OpenAlex, M. Boulanger has authored 51 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 7 papers in Pharmacology. Recurrent topics in M. Boulanger's work include Cardiac, Anesthesia and Surgical Outcomes (5 papers), Palliative Care and End-of-Life Issues (4 papers) and Adipose Tissue and Metabolism (4 papers). M. Boulanger is often cited by papers focused on Cardiac, Anesthesia and Surgical Outcomes (5 papers), Palliative Care and End-of-Life Issues (4 papers) and Adipose Tissue and Metabolism (4 papers). M. Boulanger collaborates with scholars based in United States, France and Canada. M. Boulanger's co-authors include John A. D’Orazio, Erin M. Wolf Horrell, J Duhault, Stuart G. Jarrett, Christopher W. Jones, Florence Lebon, Jean Taillefer, Frédéric Bouvier, Brian S. Finlin and Kyle W. Taylor and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

M. Boulanger

44 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Boulanger United States	13	158	151	116	83	80	51	638
Stuart Morgan United Kingdom	18	116 0.7×	220 1.5×	147 1.3×	38 0.5×	38 0.5×	36	1.4k
Ali Akbaş Türkiye	17	71 0.4×	120 0.8×	102 0.9×	38 0.5×	13 0.2×	35	717
Nidhi Gupta India	16	95 0.6×	138 0.9×	110 0.9×	32 0.4×	55 0.7×	57	765
Taeho Kim South Korea	19	52 0.3×	196 1.3×	136 1.2×	21 0.3×	48 0.6×	57	847
Lu Yao United States	13	105 0.7×	128 0.8×	71 0.6×	45 0.5×	38 0.5×	24	948
H. L. Krüskemper Germany	18	88 0.6×	164 1.1×	70 0.6×	41 0.5×	30 0.4×	86	1.1k
Freddy Contreras Venezuela	11	24 0.2×	211 1.4×	51 0.4×	29 0.3×	83 1.0×	56	567
Xiaoquan Zhu China	19	41 0.3×	403 2.7×	93 0.8×	64 0.8×	84 1.1×	55	1.0k
Dawn J. Mazzatti United Kingdom	18	49 0.3×	299 2.0×	54 0.5×	90 1.1×	57 0.7×	26	937
Jumana Saleh Oman	18	41 0.3×	254 1.7×	100 0.9×	120 1.4×	68 0.8×	38	1.3k

Countries citing papers authored by M. Boulanger

Since Specialization

Citations

This map shows the geographic impact of M. Boulanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Boulanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Boulanger more than expected).

Fields of papers citing papers by M. Boulanger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Boulanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Boulanger. The network helps show where M. Boulanger may publish in the future.

Co-authorship network of co-authors of M. Boulanger

This figure shows the co-authorship network connecting the top 25 collaborators of M. Boulanger. A scholar is included among the top collaborators of M. Boulanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Boulanger. M. Boulanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boulanger, M., Stephen Lo, Daniel Chiu, et al.. (2025). QOL-28. The experience of patients with lung cancer with brain metastases: neurocognitive deficits and patient-reported functional difficulties and mood. Neuro-Oncology. 27(Supplement_5). v386–v387.

Boulanger, M., Stephen Lo, Brian A. Jewett, et al.. (2025). Pilot Feasibility Trial of a Supportive Care Digital Application for Patients with Advanced Nonsmall Cell Lung Cancer. Journal of Palliative Medicine. 28(9). 1210–1219.

Boulanger, M., Robert Sommer, Ashley Zhou, et al.. (2024). Patient and caregiver experience with the hope and prognostic uncertainty of immunotherapy: A qualitative study.. Journal of Clinical Oncology. 42(16_suppl). 12010–12010.

Durbin, Sienna, Andrea Pelletier, Laura A. Petrillo, et al.. (2024). Financial toxicity in early‐phase cancer clinical trial participants. Cancer. 131(1). e35586–e35586. 1 indexed citations

Hsu, Melinda Laine, M. Boulanger, Cyd K. Eaton, et al.. (2024). Unmet Needs, Quality of Life, and Financial Toxicity Among Survivors of Lung Cancer. JAMA Network Open. 7(4). e246872–e246872. 12 indexed citations

Boulanger, M., et al.. (2024). Advances and future directions in ROS1 fusion-positive lung cancer. The Oncologist. 29(11). 943–956. 8 indexed citations

Boulanger, M., Riley Fadden, Kerry L. Reynolds, et al.. (2024). Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers. Supportive Care in Cancer. 32(10). 684–684. 3 indexed citations

Boulanger, M., Margaret Krasne, Ethan Gough, et al.. (2024). Outpatient Embedded Palliative Care for Patients with Advanced Thoracic Malignancy: A Retrospective Cohort Study. Current Oncology. 31(3). 1389–1399.

Boulanger, M., Ashley Zhou, Donald P. Lawrence, et al.. (2024). Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study. JCO Oncology Practice. 21(2). 178–187. 3 indexed citations

10.

Boulanger, M., et al.. (2021). Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution. The American Journal of Medicine. 134(8). 1029–1033. 11 indexed citations

11.

Finlin, Brian S., Amy L. Confides, Beibei Zhu, et al.. (2019). Adipose Tissue Mast Cells Promote Human Adipose Beiging in Response to Cold. Scientific Reports. 9(1). 8658–8658. 61 indexed citations

12.

Horrell, Erin M. Wolf, M. Boulanger, & John A. D’Orazio. (2016). Melanocortin 1 Receptor: Structure, Function, and Regulation. Frontiers in Genetics. 7. 95–95. 191 indexed citations

13.

Boulanger, M., et al.. (1997). Lack of insulin resistance in the Lyon hypertensive rat. Fundamental and Clinical Pharmacology. 11(6). 546–549. 3 indexed citations

14.

Hoffman, Robert S., et al.. (1996). Aprotinin. Annals of Pharmacotherapy. 30(4). 372–380. 17 indexed citations

15.

Cordi, A., et al.. (1995). Synthesis of 1,2-diacyl-3-nicotinoyl glycerol derivatives and evaluation of their acute effects on plasma lipids in the rat.. PubMed. 45(9). 997–1001. 1 indexed citations

16.

Boulanger, M., et al.. (1995). Latent autoimmune diabetes mellitus in adult humans with non-insulin-dependent diabetes: isPsammomys obesus a suitable animal model?. Acta Diabetologica. 32(2). 92–94. 9 indexed citations

17.

Duhault, J, et al.. (1994). S15261, a new compound for the treatment of the insulin resistance syndrome. Diabetologia. 37(10). 969–975. 11 indexed citations

18.

Pelletier, C, et al.. (1983). A simple classification of the risk in cardiac surgery. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 30(1). 61–68. 44 indexed citations

19.

Boulanger, M., et al.. (1979). Domperidone in the prevention of post-operative nausea and vomiting.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55 Suppl 1. 45–7. 6 indexed citations

20.

Duhault, J, et al.. (1976). 780 SE: A new type of hypolipemic agent. Atherosclerosis. 23(1). 63–72. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact